A focus on the association of Apol1 with kidney disease in children

被引:12
|
作者
Ekulu, Pepe M. [1 ,2 ]
Nkoy, Agathe B. [2 ]
Adebayo, Oyindamola C. [1 ]
Kazadi, Orly K. [2 ]
Aloni, Michel N. [2 ]
Arcolino, Fanny O. [1 ]
Ngiyulu, Rene M. [2 ]
Gini, Jean-Lambert E. [2 ]
Lepira, Francois B. [3 ]
van den Heuvel, Lamberthus P. [1 ,4 ]
Levtchenko, Elena N. [5 ,6 ]
机构
[1] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium
[2] Univ Kinshasa, Div Nephrol, Dept Pediat, Fac Med,Univ Hosp Kinshasa, Kinshasa, DEM REP CONGO
[3] Univ Kinshasa, Div Nephrol, Dept Internal Med, Fac Med,Univ Hosp Kinshasa, Kinshasa, DEM REP CONGO
[4] Radboud Univ Nijmegen, Dept Pediat Nephrol, Med Ctr, Nijmegen, Netherlands
[5] Katholieke Univ Leuven, Dept Pediat Nephrol, Univ Hosp Leuven, Leuven, Belgium
[6] Katholieke Univ Leuven, Dept Dev & Regenerat, Univ Hosp Leuven, Leuven, Belgium
关键词
APOL1; Chronic kidney disease; Children; Genetics; Sickle cell disease; HIV-associated nephropathy; STAGE RENAL-DISEASE; AFRICAN-AMERICAN CHILDREN; RISK VARIANTS; APOLIPOPROTEIN L1; NEPHROPATHY; GENE; GENOTYPE; OUTCOMES; ALLELES; ADULTS;
D O I
10.1007/s00467-020-04553-z
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Individuals of African origin have an increased risk of developing various progressive chronic kidney diseases (CKD). This risk has been attributed to genetic variants (G1, G2) in apolipoprotein-L1 (APOL1) gene. In the pediatric population, especially in children affected by sickle cell disease (SCD), by human immunodeficiency virus (HIV), or with various glomerular diseases, APOL1 risk variants have been associated with the development of hypertension, albuminuria, and more rapid decline of kidney function. The present review focuses on existing APOL1-related epidemiological data in children with CKD. It also includes data from studies addressing racial disparities in CKD, the APOL1-related innate immunity, and the relationship between APOL1 and CKD and pathogenic pathways mediating APOL1-related kidney injury.
引用
收藏
页码:777 / 788
页数:12
相关论文
共 50 条
  • [1] A focus on the association of Apol1 with kidney disease in children
    Pepe M. Ekulu
    Agathe B. Nkoy
    Oyindamola C. Adebayo
    Orly K. Kazadi
    Michel N. Aloni
    Fanny O. Arcolino
    Rene M. Ngiyulu
    Jean-Lambert E. Gini
    François B. Lepira
    Lamberthus P. Van den Heuvel
    Elena N. Levtchenko
    Pediatric Nephrology, 2021, 36 : 777 - 788
  • [2] A Focus on APOL1 and Kidney Disease
    Nestor, Jordan
    Mohan, Sumit
    KIDNEY INTERNATIONAL REPORTS, 2019, 4 (07): : 901 - 903
  • [3] The biology of APOL1 with insights into the association between APOL1 variants and chronic kidney disease
    Madhavan, Sethu M.
    O'Toole, John F.
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2014, 18 (02) : 238 - 242
  • [4] Kidney disease and APOL1
    Yusuf, Aminu Abba
    Govender, Melanie A.
    Brandenburg, Jean-Tristan
    Winkler, Cheryl A.
    HUMAN MOLECULAR GENETICS, 2021, 30 (R1) : R129 - R137
  • [5] The biology of APOL1 with insights into the association between APOL1 variants and chronic kidney disease
    Sethu M. Madhavan
    John F. O’Toole
    Clinical and Experimental Nephrology, 2014, 18 : 238 - 242
  • [6] APOL1 and kidney disease
    Pollak, Martin R.
    Genovese, Giulio
    Friedman, David J.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2012, 21 (02): : 179 - 182
  • [7] APOL1 Variant and Kidney Disease
    Hilliard, Constance B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (12):
  • [8] Association of APOL1 Risk Genotype and Air Pollution for Kidney Disease
    Paranjpe, Ishan
    Chaudhary, Kumardeep
    Paranjpe, Manish
    O'Hagan, Ross
    Manna, Sayan
    Jaladanki, Suraj
    Kapoor, Arjun
    Horowitz, Carol
    DeFelice, Nicholas
    Cooper, Richard
    Glicksberg, Benjamin
    Bottinger, Erwin P.
    Just, Allan C.
    Nadkarni, Girish N.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (03): : 401 - 403
  • [9] Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
    Genovese, Giulio
    Friedman, David J.
    Ross, Michael D.
    Lecordier, Laurence
    Uzureau, Pierrick
    Freedman, Barry I.
    Bowden, Donald W.
    Langefeld, Carl D.
    Oleksyk, Taras K.
    Knob, Andrea L. Uscinski
    Bernhardy, Andrea J.
    Hicks, Pamela J.
    Nelson, George W.
    Vanhollebeke, Benoit
    Winkler, Cheryl A.
    Kopp, Jeffrey B.
    Pays, Etienne
    Pollak, Martin R.
    SCIENCE, 2010, 329 (5993) : 841 - 845
  • [10] Inhibiting APOL1 to Treat Kidney Disease
    Williams, Winfred W.
    Ingelfinger, Julie R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (11): : 1045 - 1049